Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Biomarkers: Technologies and Global Markets | Mar 2011 | £3,065 | 100% |
| Cancer Biomarkers Adoption Is Driving Growth |
Jul 2008 | £2,370 | 94% |
| Key Trends In Drug-diagnostic Co-development: Identifying collaborative opportunities and navigating regulatory challenges | Jun 2009 | £2,425 | 92% |
| Advances in the Use of Biomarkers in Biochip and Microarray Testing Innovative technologies, growth opportunities and the future market outlook |
Oct 2009 | £2,425 | 88% |
| Multiplex Assays Evolving Technologies, Applications and Future Directions |
Jan 2010 | £2,370 | 87% |
| Mass Spectroscopy for Clinical Laboratory Analysis | Nov 2011 | £2,150 | 87% |
| Companion Biomarkers in Drug Development | Apr 2009 | £2,150 | 86% |
| Central and Core Laboratories | Oct 2011 | £1,195 | 86% |
| Innovations in Bioinformatics Emerging Tools for Drug Discovery and Development |
Jan 2008 | £2,425 | 85% |
| Biomarker Technology Platforms for Cancer Diagnoses and Therapies | Sep 2011 | £2,150 | 85% |
| Multiplex Assays in Translational Medicine Technologies, Applications, and Future Directions |
Feb 2008 | £710 | 82% |
| Molecular Diagnostics in Cancer Testing | Jul 2011 | £2,150 | 81% |
| Molecular Diagnostics in Infectious Disease Testing | Jul 2011 | £2,150 | 81% |
| Companion Diagnostics in Personalized Medicine and Cancer Therapy | Jul 2011 | £2,150 | 80% |
| Biomedical Imaging From Drug Target Discovery to Medical Diagnostics |
Dec 2008 | £2,370 | 77% |
| Biomarkers (2 parts) Technologies, Markets and Companies |
Jan 2012 | £3,240 | 77% |
| The Worldwide Market for Cancer Diagnostics 4th Edition |
Apr 2010 | £2,655 | 77% |
| Alzheimer's disease Technologies, Markets and Companies |
Jan 2012 | £2,265 | 74% |
| Global Clinical Trial Business Report & Analysis 20082018 | Jul 2008 | £1,499 | 72% |
| Transforming Drug Discovery through Genomics and Proteomics | Jan 2009 | £155 | 69% |
| Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine) |
Jun 2008 | £1,895 | 68% |
| Pharmacodiagnostics and Personalized Medicine 2009 (Markets, Challenges, Forecasts and Key Players) |
Apr 2009 | £2,215 | 67% |
| The Executive Guide to Molecular Imaging | Jul 2007 | £595 | 67% |
| What's Hot in Cancer Drug R&D? | Jul 2006 | £295 | 66% |
| DNA sequencing Technologies, Markets and Companies |
Jan 2012 | £1,815 | 66% |
| Gene Expression Profiling Markets | Jan 2008 | £2,525 | 65% |
| MicroRNA Research Tools 2008 | Jan 2008 | £1,540 | 65% |
| Central and Core Laboratories | Oct 2007 | £995 | 64% |
| The Global Pain Therapeutics Market 4th Edition: Market Trends & R&D Insights |
Nov 2010 | £1,105 | 63% |
| HighGrowth Diagnostic Markets | Nov 2008 | £2,150 | 61% |
